MedPath

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.hopkinsmedicine.org/kimmel_cancer_center

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Interventions
Drug: Intraductal arm
Drug: Intravenous arm
First Posted Date
2006-02-13
Last Posted Date
2013-10-31
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
20
Registration Number
NCT00290732
Locations
🇺🇸

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2006-02-07
Last Posted Date
2018-12-06
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
86
Registration Number
NCT00287989
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
First Posted Date
2006-02-07
Last Posted Date
2018-03-01
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
30
Registration Number
NCT00287872
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study

Not Applicable
Terminated
Conditions
Lymphedema
Breast Cancer
First Posted Date
2006-01-26
Last Posted Date
2017-01-24
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
400
Registration Number
NCT00282529
Locations
🇺🇸

Avon Breasts Center, Johns Hopkins Medical Institutions, Baltimore,, Maryland, United States

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2006-01-25
Last Posted Date
2019-01-17
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
50
Registration Number
NCT00281970
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
First Posted Date
2006-01-25
Last Posted Date
2016-10-12
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
37
Registration Number
NCT00281866
Locations
🇪🇸

Hospital Universitario 12 de Octubre, Madrid, Spain

🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Leukemia
Lymphoma
Interventions
Biological: Pegfilgrastim
Biological: Rituximab
First Posted Date
2006-01-18
Last Posted Date
2018-11-05
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
94
Registration Number
NCT00278161
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD

Phase 1
Terminated
Conditions
Lymphoproliferative Disorder
Interventions
Biological: Inactivated EBV-infected vaccine
First Posted Date
2006-01-18
Last Posted Date
2023-04-25
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
23
Registration Number
NCT00278200
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Partial Breast Irradiation With Chemotherapy

Phase 1
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2006-01-18
Last Posted Date
2020-02-19
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
27
Registration Number
NCT00278109
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

Phase 2
Completed
Conditions
Leukemia
First Posted Date
2006-01-13
Last Posted Date
2014-04-17
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registration Number
NCT00276601
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

🇺🇸

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath